How to Talk to Your Doctor About Peptide Therapy Safely and Effectively

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Patients should present specific symptoms and desired outcomes when discussing peptide therapy with their doctor, including relevant lab values such as IGF-1 and growth hormone levels. Asking about evidence-based dosing regimens and monitoring plans improves safety and treatment success.

Understand Key Clinical Markers Before Your Appointment

Serum IGF-1 levels ranging from 150 to 250 ng/mL often indicate candidates who might benefit from peptide therapy like sermorelin or ipamorelin. Presenting this data from recent blood tests helps your doctor objectively assess your status and whether peptides are appropriate.

Prepare Clear Goals Based on Symptoms and Lab Values

Doctors look for concrete reasons before prescribing peptides. Fatigue linked with low IGF-1, muscle loss coinciding with declining growth hormone, or delayed wound healing are clinical signs that support peptide therapy. Tell your doctor exactly what you want to achieve—be it increased energy, improved sleep, or muscle recovery—and provide lab values that reflect your baseline.

Example Goals to Discuss

• Improve serum IGF-1 from 130 ng/mL to above 180 ng/mL
• Enhance muscle mass by increasing growth hormone pulsatility
• Shorten wound healing time by promoting collagen synthesis

Ask About Evidence-Based Dosing and Administration

For instance, clinical studies by Dr. Daniel Rudman (1990) suggest starting sermorelin at 200mcg subcutaneously once daily at bedtime to mimic physiologic GH pulses. Contrast this with higher doses like 500mcg daily which may increase side effects without added benefit. Different peptides have different profiles; ipamorelin at 300mcg twice daily often induces less cortisol elevation than GHRP-6, which can impact adrenal function.

Discuss Monitoring Plans and Timeframes

Peptide effects occur over weeks to months. Benchmarks at 3 and 6 months typically include retesting IGF-1, glucose tolerance, and cardiovascular markers. Be upfront: some patients experience side effects like injection site irritation or mild edema, and your doctor should monitor these closely.

Common Misunderstandings to Clarify with Your Doctor

• Peptides are not anabolic steroids. They stimulate endogenous hormone release rather than replacing it.
• Peptide therapy outcomes vary—body weight, age, and baseline hormone levels influence response.
• Higher doses don’t always equate to better results; side effects can increase.

How Peptide Therapy Compares with Traditional Hormone Replacement

Unlike exogenous growth hormone therapy, peptides stimulate the pituitary gland to release GH in pulses, maintaining more natural rhythms and reducing risks like insulin resistance. However, peptide therapy requires intact pituitary function, limiting use in patients with pituitary damage or tumors.

Clinical Takeaway

Before starting peptides, bring recent IGF-1 and GH lab results, clear symptom-based goals, and inquire about peptide-specific dosing regimens and monitoring protocols. This structured conversation improves your doctor’s ability to tailor therapy, balance efficacy with safety, and track your progress meaningfully over time.